{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:18:57Z","timestamp":1791501537952,"version":"4.3.4"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T00:00:00Z","timestamp":1650585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Long-term peritoneal dialysis as currently performed, causes structural and functional alterations of the peritoneal dialysis membrane. This decay is brought about by the continuous exposure to commercially available glucose-based dialysis solutions. This review summarizes our knowledge on the peritoneum in the initial phase of PD, during the first 2\u00a0years and the alterations in function and morphology in long-term PD patients. The pseudohypoxia hypothesis is discussed and how this glucose-induced condition can be used to explain all peritoneal alterations in long-term PD patients. Special attention is paid to the upregulation of hypoxia inducing factor-1 and the subsequent stimulation of the genes coding for glucose transporter-1 (GLUT-1) and the growth factors transforming growth factor-\u03b2 (TGF\u03b2), vascular endothelial growth factor (VEGF), plasminogen growth factor activator inhibitor-1 (PAI-1) and connective tissue growth factor (CTGF). It is argued that increased pseudohypoxia-induced expression of GLUT-1 in interstitial fibroblasts is the key factor in a vicious circle that augments ultrafiltration failure. The practical use of the protein transcripts of the upregulated growth factors in peritoneal dialysis effluent is considered. The available and developing options for prevention and treatment are examined. It is concluded that low glucose degradation products\/neutral pH, bicarbonate buffered solutions with a combination of various osmotic agents all in low concentration, are currently the best achievable options, while other accompanying measures like the use of RAAS inhibitors and tamoxifen may be valuable. Emerging developments include the addition of alanyl glutamine to the dialysis solution and perhaps the use of nicotinamide mononucleotide, available as nutritional supplement.<\/jats:p>","DOI":"10.3389\/fphys.2022.885802","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T08:26:56Z","timestamp":1651134416000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Aging of the Peritoneal Dialysis Membrane"],"prefix":"10.3389","volume":"13","author":[{"given":"Raymond T.","family":"Krediet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"B1","first-page":"928","article-title":"Glucose Transporter GLUT-1 Expression Correlates with Tumor Hypoxia and Predicts Metastasis-free Survival in Advanced Carcinoma of the Cervix","volume":"7","author":"Airley","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.ajkd.2005.08.011","article-title":"Mesenchymal Conversion of Mesothelial Cells as a Mechanism Responsible for High Solute Transport Rate in Peritoneal Dialysis: Role of Vascular Endothelial Growth Factor","volume":"46","author":"Aroeira","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/biom10111573","article-title":"SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate","volume":"10","author":"Balzer","year":"2020","journal-title":"Biomolecules"},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/ndt\/gfq343","article-title":"Early Detection of Imminent Encapsulating Peritoneal Sclerosis; Free Water Transport, Selected Effluent Proteins or Both","volume":"39","author":"Barreto","year":"2019","journal-title":"Perit Dial. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3747\/pdi.2012.01063","article-title":"Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used as Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?","volume":"33","author":"Barreto","year":"2013","journal-title":"Perit Dial. Int."},{"key":"B6","first-page":"280","article-title":"Xylitol as Osmotic Agent in CAPD: an Alternative to Glucose for Uremic Diabetic Patients?","volume":"28","author":"Bazzato","year":"1982","journal-title":"Trans. Am. Soc. Artif. Intern. Organs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.3390\/ijms22157955","article-title":"How to Improve the Biocompatibility of Peritoneal Dialysis Solutions ( without Jeopardizing the Patient\u2019s Health)","volume":"22","author":"Bonomini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ki.2011.117","article-title":"L-carnitine Is an Osmotic Agent Suitable for Peritoneal Dialysis","volume":"80","author":"Bonomini","year":"2011","journal-title":"Kidney Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3747\/pdi.2012.00189","article-title":"Longitudinal Analysis of Peritoneal Fluid Transport and its Determinants in a Cohort of Incident Peritoneal Dialysis Patients","volume":"34","author":"Coester","year":"2014","journal-title":"Peritoneal Dial. Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1681\/asn.v114717","article-title":"Vascular Proliferation and Enhanced Expression of Endothelial Nitric Oxide Synthase in Human Peritoneum Exposed to Long-Term Peritoneal Dialysis","volume":"11","author":"Combet","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e46557","DOI":"10.15252\/embr.201846557","article-title":"Tamoxifen Mechanically Reprograms the Tumor Microenvironment via HIF-1A and Reduces Cancer Cell Survival","volume":"20","author":"Cortes","year":"2019","journal-title":"EMBO Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00441-016-2461-3","article-title":"Hypoxia in Tissue Repair and Fibrosis","volume":"365","author":"Darby","year":"2016","journal-title":"Cell Tissue Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/oxfordjournals.ndt.a092275","article-title":"Clinical Evaluation of the Peritoneal Equilibration Test: a Population-Based Study","volume":"8","author":"Davies","year":"1993","journal-title":"Nephrol. Dial. Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/j.1523-1755.2004.66021.x","article-title":"Longitudinal Relationship between Solute Transport and Ultrafiltration Capacity in Peritoneal Dialysis Patients","volume":"66","author":"Davies","year":"2004","journal-title":"Kidney Int."},{"key":"B15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3747\/pdi.2008.00159","article-title":"The Effects of a Dialysis Solution with a Combination of Glycerol\/Amino Acids\/Dextrose on the Peritoneal Membrane in Chronic Renal Failure","volume":"30","author":"De Graaff","year":"2010","journal-title":"Perit Dial. Int."},{"key":"B16","first-page":"32","article-title":"Clinical Experience with Tamoxifen in Peritoneal Fibrosing Syndromes","volume":"19","author":"Del Peso","year":"2003","journal-title":"Adv. Perit Dial."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1038\/sj.ki.5002598","article-title":"Epithelial-to-mesenchymal Transition of Mesothelial Cells Is an Early Event during Peritoneal Dialysis and Is Associated with High Peritoneal Transport","volume":"73","author":"Del Peso","year":"2008","journal-title":"Kidney Int."},{"key":"B18","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"Dipeptide Alanyl-Glutamine Ameliorates Peritoneal Fibrosis and Attenuates Il-17 Dependent Pathways during Peritoneal Dialysis","volume":"89","author":"Ferantelli","year":"2016","journal-title":"Kidney Int."},{"key":"B19","first-page":"615","article-title":"Vascular Endothelial Growth Factor. The Trigger for Neovascularization in the Eye","volume":"72","author":"Ferrara","year":"1995","journal-title":"Lab. Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"F861","DOI":"10.1152\/ajprenal.1994.267.5.f861","article-title":"Osmotic Barrier of the Parietal Peritoneum","volume":"267","author":"Flessner","year":"1994","journal-title":"Am. J. Physiology-Renal Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The Hallmarks of Mitochondrial Dysfunction in Chronic Kidney Disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/j.1523-1755.2005.00357.x","article-title":"Genetic and Clinical Factors Influence the Baseline Permeability of the Peritoneal Membrane","volume":"67","author":"Gillerot","year":"2005","journal-title":"Kidney Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/iub.572","article-title":"The Monocarboxylate Transporter Family-Role and Regulation","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"key":"B24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fcell.2020.00246","article-title":"Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism","volume":"8","author":"Hong","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1507\/endocrj.ej19-0313","article-title":"Effect of Oral Administration of Nicotinamide Mononucleotide on Clinical Parameters and Nicotinamide Metabolite Levels in Healthy Japanese Men","volume":"67","author":"Irie","year":"2020","journal-title":"Endocr. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000070993","article-title":"Glucose Degradation Products in Peritoneal Dialysis: from Bench to Bedside","volume":"26","author":"J\u00f6rres","year":"2003","journal-title":"Kidney Blood Press. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/ndt\/gfn421","article-title":"A Positive Effect of AII Inhibitors on Peritoneal Membrane Function in Long-Term PD Patients","volume":"24","author":"Kolesnyk","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"B28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/089686080702700413","article-title":"Impact of ACE Inhibitors and AII Receptor Blockers on Peritoneal Membrane Transport Characteristics in Long-Term Peritoneal Dialysis Patients","volume":"27","author":"Kolesnyk","year":"2007","journal-title":"Perit Dial. Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/ndt\/gfq362","article-title":"Tamoxifen Is Associated with Lower Mortality of Encapsulating Peritoneal Sclerosis: Results of the Dutch Multicentre EPS Study","volume":"26","author":"Korte","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"B30","first-page":"124","article-title":"Can Free Water Transport Be Used as a Clinical Parameter for Peritoneal Fibrosis in Long-Term PD Patients?","volume":"35","author":"Krediet","year":"2015","journal-title":"Perit Dial. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"CJN.15371121","DOI":"10.2215\/cjn.15371121","article-title":"Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients","volume":"2022","author":"Krediet","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ndt\/17.suppl_3.16","article-title":"Clinical Advantages of New Peritoneal Dialysis Solutions","volume":"17","author":"Krediet","year":"2002","journal-title":"Nephrol. Dial. Transpl."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1681\/asn.2021010080","article-title":"Acquired Decline in Ultrafiltration in Peritoneal Dialysis: the Role of Glucose","volume":"32","author":"Krediet","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/cn109596","article-title":"Peritoneal Vasculopathy in the Pathophysiology of Long-Term Ultrafiltration Failure: A Hypothesis Based on Clinical Observations","volume":"91","author":"Krediet","year":"2019","journal-title":"Clin. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3389\/fphys.2018.01815","article-title":"Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated with Peritoneal Dialysis","volume":"9","author":"Krediet","year":"2018","journal-title":"Front. Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/j.1440-1797.2011.01496.x","article-title":"Association between Interleukin-10 Gene Polymorphism -592 (A\/C) and Peritoneal Transport in Patients Undergoing Peritoneal Dialysis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/nejm199311113292004","article-title":"The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1681\/asn.v12102029","article-title":"Gene Transfer of Transforming Growth Factor-\u03921 to the Rat Peritoneum: Effects on Membrane Function","volume":"12","author":"Margetts","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/08968608211008095","article-title":"SGLT2 Inhibition Does Not Reduce Glucose Absorption during Experimental Peritoneal Dialysis","volume":"41","author":"Martus","year":"2021","journal-title":"Perit Dial. Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.3390\/nu13072282","article-title":"Biological Effects of XyloCore, a Glucose Sparing PD Solution, on Mesothelial Cells: Focus on Mesothelial-Mesenchymal Transition, Inflammation and Angiogenesis","volume":"13","author":"Masola","year":"2021","journal-title":"Nutrients"},{"key":"B41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and Interstitial Changes in the Peritoneum of CAPD Patients with Peritoneal Sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit Dial. Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/089686088700700105","article-title":"Potential Hazards of Glycerol Dialysate in Diabetic CAPD Patients","volume":"7","author":"Matthys","year":"1987","journal-title":"Perit Dial. Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"F721","DOI":"10.1152\/ajprenal.00368.2009","article-title":"Connective Tissue Growth Factor (CTGF\/CCN2) Is Increased in Peritoneal Dialysis Patients with High Peritoneal Solute Transport Rate","volume":"298","author":"Mizutani","year":"2010","journal-title":"Am. J. Physiology-Renal Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1681\/asn.2014090939","article-title":"Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis","volume":"26","author":"Morelle","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/0896860819878344","article-title":"Advanced Glycation End Products Are Associated with Immature Angiogenesis and Peritoneal Dysfunction in Patients on Peritoneal Dialysis","volume":"40","author":"Nakano","year":"2020","journal-title":"Perit Dial. Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12551-015-0186-2","article-title":"Glucose Transporters: Physiological and Pathological Roles","volume":"8","author":"Navale","year":"2016","journal-title":"Biophys. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/sj.ki.5000285","article-title":"Aquaporin-1 Plays an Essential Role in Water Permeability and Ultrafiltration during Peritoneal Dialysis","volume":"69","author":"Ni","year":"2006","journal-title":"Kidney Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1042\/bj2950067","article-title":"Differential Control of the Functional Cell Surface Expression and Content of Hexose Transporter GLUT-1 by Glucose and Glucose Metabolism in Murine Fibroblasts","volume":"295","author":"Ortiz","year":"1993","journal-title":"Biochem. J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1152\/ajplegacy.1951.167.1.13","article-title":"Filtration, Diffusion and Molecular Sieving through Peripheral Capillary Membranes; a Contribution to the Pore Theory of Capillary Permeability","volume":"167","author":"Pappenheimer","year":"1951","journal-title":"Am. J. Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8968608211027008","DOI":"10.1177\/08968608211027008","article-title":"Do low GDP Neutral pH Solutions Prevent or Retard Peritoneal Membrane Alterations in Long-Term Peritoneal Dialysis?","volume":"2021","author":"Parikova","year":"2021","journal-title":"Perit Dial. Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1093\/ndt\/gfm768","article-title":"Free Water Transport, Small Pore Transport and the Osmotic Pressure Gradient","volume":"23","author":"Parikova","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/toxins13030174","article-title":"A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience","volume":"13","author":"Rago","year":"2021","journal-title":"Toxins"},{"key":"B53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cbic.201900544","article-title":"Small-molcule Inhibition of Glucose Transporters GLUT-1-4","volume":"21","author":"Reckeh","year":"2020","journal-title":"ChemBioChem"},{"key":"B54","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/089686089301302S09","article-title":"A Three-Pore Model of Peritoneal Transport","volume":"13","author":"Rippe","year":"1993","journal-title":"Perit Dial. Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/ki.1989.115","article-title":"Simulations of Peritoneal Solute Transport during CAPD. Application of Two-Pore Formalism","volume":"35","author":"Rippe","year":"1989","journal-title":"Kidney Int."},{"key":"B56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1177\/089686080802800512","article-title":"Evitar (L-Alanyl-L-Glutamine) Regulates Key Signaling Molecules in the Pathogenesis of Postoperative Tissue Fibrosis","volume":"26","author":"Robertson","year":"2019","journal-title":"Reprod. Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/ndt\/gfq343","article-title":"The Time Course of Peritoneal Transport Parameters in Peritoneal Dialysis Patients Who Develop Encapsulating Peritoneal Sclerosis","volume":"26","author":"Sampimon","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/labinvest.2010.111","article-title":"PPAR-\u03b3 Agonist Rosiglitazone Protects Peritoneal Membrane from Dialysis Fluid-Induced Damage","volume":"90","author":"Sandoval","year":"2010","journal-title":"Lab. Invest."},{"key":"B59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0272-6386(12)80814-6","article-title":"Functional Longevity of the Human Peritoneum: How Long Is Continuous Peritoneal Dialysis Possible? Results of a Prospective Medium Long-Term Study","volume":"23","author":"Selgas","year":"1994","journal-title":"Am. J. Kidney Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"iv63","DOI":"10.1093\/ndtplus\/sfn127","article-title":"Treatment of Severe Ultrafiltration Failure with Nonglucose Dialysis Solutions in Patients with and without Peritoneal Sclerosis","volume":"1","author":"Smit","year":"2008","journal-title":"NDT Plus"},{"key":"B61","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/089686080302300507","article-title":"Peritoneal Function and Assessment of Reference Values Using a 3.86% Glucose Solution","volume":"23","author":"Smit","year":"2003","journal-title":"Perit Dial. Int."},{"key":"B62","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/ndt\/gfy313","article-title":"Alterations of Peritoneal Transport Characteristics in Dialysis Patients with Ultrafiltration Failure: Tissue and Capillary Components","volume":"34","author":"Stachowska-Pietka","year":"2019","journal-title":"Nephrol. Dial. Transpl."},{"key":"B63","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/089686088700700306","article-title":"Peritoneal Equilibration Test","volume":"7","author":"Twardowski","year":"1987","journal-title":"Perit Dial. Int."},{"key":"B64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/089686080402400304","article-title":"A Randomized Clinical Trial with a 0.6% Amino Acid\/1.4% Glycerol Peritoneal Dialysis Solution","volume":"24","author":"Van Biesen","year":"2004","journal-title":"Perit Dial. Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.ekir.2020.09.047","article-title":"Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility","volume":"5","author":"Van Diepen","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/089686080402400615","article-title":"Determinants of Peritoneal Solute Transport Rates in Newly Started Nondiabetic Peritoneal Dialysis Patients","volume":"24","author":"van Esch","year":"2004","journal-title":"Perit Dial. Int."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1177\/089686080502503s05","article-title":"Effects of Inhibition of the Polyol Pathway during Chronic Peritoneal Exposure to a Dialysis Solution","volume":"25","author":"van Westrhenen","year":"2005","journal-title":"Perit Dial. Int."},{"key":"B68","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/089686080802800512","article-title":"A Pyruvate-Buffered Dialysis Fluid Induces Less Peritoneal Angiogenesis and Fibrosis Than a Conventional Solution","volume":"28","author":"van Westrhenen","year":"2008","journal-title":"Perit Dial. Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.kint.2018.08.031","article-title":"A Randomized Controlled Trial of Alanyl-Glutamine Supplementation in Peritoneal Dialysis Fluid to Assess Impact on Biomarkers of Peritoneal Health","volume":"94","author":"Vychytil","year":"2018","journal-title":"Kidney Int."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3389\/fphys.2018.01961","article-title":"Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine","volume":"9","author":"Wiesenhofer","year":"2019","journal-title":"Front. Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/asn.v132470","article-title":"Morphologic Changes in the Peritoneal Membrane of Patients with Renal Disease","volume":"13","author":"Williams","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/diabetes.42.6.801","article-title":"Hyperglycemic Pseudohypoxia and Diabetic Complications","volume":"42","author":"Williamson","year":"1993","journal-title":"Diabetes"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1046\/j.1523-1755.2003.00883.x","article-title":"Glucose-mediated Induction of TGF-\u03921 and MCP-1 in Mesothelial Cells In Vitro Is Osmolality and Polyol Pathway Dependent","volume":"63","author":"Wong","year":"2003","journal-title":"Kidney Int."},{"key":"B74","first-page":"354","article-title":"Immunohistochemical Study of Human Advanced Glycosylation End-Products (AGE) in Chronic Renal Failure","volume":"42","author":"Yamada","year":"1994","journal-title":"Clin. Nephrol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/nejmoa020809","article-title":"Peritoneal Dialysis and Epithelial-To-Mesenchymal Transition of Mesothelial Cells","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0022-2143(99)90116-6","article-title":"Growth Factors VEGF and TGF-\u03921 in Peritoneal Dialysis","volume":"134","author":"Zweers","year":"1999","journal-title":"J. Lab. Clin. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1067\/mlc.2001.112235","article-title":"Vascular Endothelial Growth Factor in Peritoneal Dialysis: A Longitudinal Follow-Up","volume":"137","author":"Zweers","year":"2001","journal-title":"J. Lab. Clin. Med."}],"updated-by":[{"DOI":"10.3389\/fphys.2022.950933","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000}}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.885802\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T20:46:54Z","timestamp":1661201214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.885802\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":77,"alternative-id":["10.3389\/fphys.2022.885802"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.885802","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphys.2022.950933","asserted-by":"object"}]},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,22]]},"article-number":"885802"}}